{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:34:28Z","timestamp":1791178468410,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Melanocyte differentiation Ags, including tyrosinase-related protein (TRP) 1, are relevant to both autoimmune skin depigmentation (vitiligo) and tumor immunity, because they are expressed by both benign melanocytes and many malignant melanomas. Melanoma patients generate CD4+ T cells that specifically recognize these proteins. TRP1 contains internal disulfide bonds and is presented by MHC class II molecules. \u03b3-IFN\u2013inducible lysosomal thiol reductase (GILT) facilitates the generation of class II-binding peptides by the endocytic reduction of protein disulfide bonds. We show in this study that GILT is required for efficient MHC class II-restricted processing of a TRP1 epitope in vitro and accelerates the onset of vitiligo in TRP1-specific TCR transgenic mice. The presence of GILT confers a small increase in the percentage of autoreactive T cells with an effector memory phenotype that may contribute to earlier disease onset. The onset of vitiligo is associated with a greater increase in the percentage of autoreactive T cells with an effector memory phenotype. Given that many self and tumor Ags have disulfide bonds and are presented on MHC class II, GILT is likely to be important in the pathogenesis of other CD4+ T cell-mediated autoimmune diseases and for the development of effective cancer immunotherapy.<\/jats:p>","DOI":"10.4049\/jimmunol.1000945","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T02:23:24Z","timestamp":1280370204000},"page":"2828-2835","source":"Crossref","is-referenced-by-count":49,"title":["GILT Accelerates Autoimmunity to the Melanoma Antigen Tyrosinase-Related Protein 1"],"prefix":"10.1093","volume":"185","author":[{"given":"Matthew P","family":"Rausch","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Arizona , Phoenix, AZ 85004"},{"name":"Arizona Cancer Center, University of Arizona , Tucson, AZ 85724"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari R","family":"Irvine","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Antony","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P","family":"Restifo","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cresswell","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, Yale University , New Haven, CT 06520"},{"name":"Department of Immunobiology, School of Medicine, Yale University , New Haven, CT 06520"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Taraszka","family":"Hastings","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, University of Arizona , Phoenix, AZ 85004"},{"name":"Arizona Cancer Center, University of Arizona , Tucson, AZ 85724"},{"name":"Department of Immunobiology, College of Medicine, University of Arizona , Tucson, AZ 85724"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"2025032411505468300_r1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1073\/pnas.97.2.745","article-title":"Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT)","volume":"97","author":"Arunachalam","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411505468300_r2","doi-asserted-by":"crossref","first-page":"22573","DOI":"10.1074\/jbc.M101851200","article-title":"Cathepsin S regulates the expression of cathepsin L and the turnover of \u03b3-interferon-inducible lysosomal thiol reductase in B lymphocytes","volume":"276","author":"Honey","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2025032411505468300_r3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-0854.2007.00600.x","article-title":"Innate immune recognition triggers secretion of lysosomal enzymes by macrophages","volume":"8","author":"Lackman","year":"2007","journal-title":"Traffic"},{"key":"2025032411505468300_r4","doi-asserted-by":"crossref","first-page":"12036","DOI":"10.1016\/S0021-9258(18)37889-X","article-title":"Molecular and biochemical characterization of a novel \u03b3-interferon-inducible protein","volume":"263","author":"Luster","year":"1988","journal-title":"J. Biol. Chem."},{"key":"2025032411505468300_r5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.1065500","article-title":"Defective antigen processing in GILT-free mice","volume":"294","author":"Maric","year":"2001","journal-title":"Science"},{"key":"2025032411505468300_r6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.20011853","article-title":"Absence of \u03b3-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes","volume":"195","author":"Haque","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r7","doi-asserted-by":"crossref","first-page":"25907","DOI":"10.1074\/jbc.M003459200","article-title":"Gamma-interferon-inducible lysosomal thiol reductase (GILT): maturation, activity, and mechanism of action","volume":"275","author":"Phan","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025032411505468300_r8","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.4049\/jimmunol.177.12.8569","article-title":"Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing","volume":"177","author":"Hastings","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411505468300_r9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CVI.00412-07","article-title":"Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities","volume":"15","author":"Sealy","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"2025032411505468300_r10","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.163.11.5820","article-title":"A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses","volume":"163","author":"Wang","year":"1999","journal-title":"J. Immunol."},{"key":"2025032411505468300_r11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1034\/j.1600-0749.2002.02012.x","article-title":"Molecular anatomy of tyrosinase and its related proteins: beyond the histidine-bound metal catalytic center","volume":"15","author":"Garc\u00eda-Borr\u00f3n","year":"2002","journal-title":"Pigment Cell Res."},{"key":"2025032411505468300_r12","doi-asserted-by":"crossref","first-page":"32200","DOI":"10.1074\/jbc.M005186200","article-title":"Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing","volume":"275","author":"Negroiu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2025032411505468300_r13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2025032411505468300_r15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","article-title":"Cytotoxic T lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"121","author":"Mandelcorn-Monson","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"2025032411505468300_r16","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"2025032411505468300_r18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"2025032411505468300_r19","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.0600199103","article-title":"Genomic anatomy of the Tyrp1 (brown) deletion complex","volume":"103","author":"Smyth","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411505468300_r20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20091918","article-title":"Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts","volume":"207","author":"Quezada","year":"2010","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20091921","article-title":"Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma","volume":"207","author":"Xie","year":"2010","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r22","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4+ T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411505468300_r23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2025032411505468300_r24","first-page":"271","article-title":"Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo","volume":"65","author":"Fusenig","year":"1978","journal-title":"Bull. Cancer"},{"key":"2025032411505468300_r25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.176.6.1693","article-title":"Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte\/macrophage colony-stimulating factor","volume":"176","author":"Inaba","year":"1992","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r26","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.4049\/jimmunol.177.7.4369","article-title":"Inhibitory role of IFN-gamma-inducible lysosomal thiol reductase in T cell activation","volume":"177","author":"Barjaktarevi\u0107","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411505468300_r27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.iy.08.040190.002531","article-title":"Developmental biology of T cells in T cell-receptor transgenic mice","volume":"8","author":"von Boehmer","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411505468300_r28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0092-8674(92)90453-J","article-title":"Exclusion and inclusion of alpha and beta T cell receptor alleles","volume":"69","author":"Borgulya","year":"1992","journal-title":"Cell"},{"key":"2025032411505468300_r29","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.169.4.2141","article-title":"A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter","volume":"169","author":"McGargill","year":"2002","journal-title":"J. Immunol."},{"key":"2025032411505468300_r30","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.4049\/jimmunol.169.10.6036","article-title":"Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma","volume":"169","author":"Robbins","year":"2002","journal-title":"J. Immunol."},{"key":"2025032411505468300_r31","first-page":"5144","article-title":"Expression of a \u201cself-\u201dantigen by human tumor cells enhances tumor antigen-specific CD4+ T-cell function","volume":"62","author":"Touloukian","year":"2002","journal-title":"Cancer Res."},{"key":"2025032411505468300_r32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1084\/jem.188.8.1473","article-title":"Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells","volume":"188","author":"Delon","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r33","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1091\/mbc.12.11.3451","article-title":"Pmel17 initiates premelanosome morphogenesis within multivesicular bodies","volume":"12","author":"Berson","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"2025032411505468300_r34","first-page":"296","article-title":"CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase","volume":"58","author":"Kobayashi","year":"1998","journal-title":"Cancer Res."},{"key":"2025032411505468300_r35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00002371-200403000-00001","article-title":"Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein","volume":"27","author":"Parkhurst","year":"2004","journal-title":"J. Immunother."},{"key":"2025032411505468300_r36","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1084\/jem.183.5.1965","article-title":"Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes","volume":"183","author":"Topalian","year":"1996","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r37","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.164.7.3535","article-title":"Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice","volume":"164","author":"Touloukian","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411505468300_r38","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1074\/jbc.M708998200","article-title":"An unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase","volume":"283","author":"Bogunovic","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2025032411505468300_r39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4049\/jimmunol.182.2.746","article-title":"Cutting edge: developmental up-regulation of IFN-gamma-inducible lysosomal thiol reductase expression leads to reduced T cell sensitivity and less severe autoimmunity","volume":"182","author":"Maric","year":"2009","journal-title":"J. Immunol."},{"key":"2025032411505468300_r40","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","article-title":"CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions","volume":"177","author":"Lambe","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411505468300_r41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.179.2.993","article-title":"Deletional self-tolerance to a melanocyte\/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes","volume":"179","author":"Nichols","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411505468300_r42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J. Immunol."},{"key":"2025032411505468300_r43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.138.4.1310","article-title":"Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes","volume":"138","author":"Tsujisaki","year":"1987","journal-title":"J. Immunol."},{"key":"2025032411505468300_r44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF00509079","article-title":"Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes","volume":"277","author":"Aub\u00f6ck","year":"1985","journal-title":"Arch. Dermatol. Res."},{"key":"2025032411505468300_r45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2133.1998.02550.x","article-title":"Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules","volume":"139","author":"Hedley","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"2025032411505468300_r46","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.134.6.4226","article-title":"Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells","volume":"134","author":"Herlyn","year":"1985","journal-title":"J. Immunol."},{"key":"2025032411505468300_r47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.160.1.255","article-title":"Surface antigens of melanoma and melanocytes: specificity of induction of Ia antigens by human gamma-interferon","volume":"160","author":"Houghton","year":"1984","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r48","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","article-title":"A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders","volume":"151","author":"Le Poole","year":"1993","journal-title":"J. Immunol."},{"key":"2025032411505468300_r49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.189.5.871","article-title":"Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DR11","volume":"189","author":"Manici","year":"1999","journal-title":"J. Exp. Med."},{"key":"2025032411505468300_r50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1073\/pnas.97.1.400","article-title":"Melan-A\/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells","volume":"97","author":"Zarour","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/5\/2828\/61611633\/1000945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/5\/2828\/61611633\/1000945.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:47:38Z","timestamp":1743205658000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/185\/5\/2828\/7977766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1000945","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,9]]},"published":{"date-parts":[[2010,9,1]]}}}